{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:08:38Z","timestamp":1793650118801,"version":"4.5.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaut.2021.102634","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:53:59Z","timestamp":1618970039000},"page":"102634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Autoreactive T cells and their role in atopic dermatitis"],"prefix":"10.1016","volume":"120","author":[{"given":"Tina","family":"De Bruyn Carlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariza Mishaal Saiema","family":"Badloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-1131","authenticated-orcid":false,"given":"Inge","family":"Kortekaas Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.14888","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2015.12.1306","article-title":"Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy","volume":"137","author":"Kim","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/jdv.13679","article-title":"TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis","volume":"30","author":"Nygaard","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"244","key":"10.1016\/j.jaut.2021.102634_bib5","doi-asserted-by":"crossref","first-page":"244ra90","DOI":"10.1126\/scitranslmed.3008946","article-title":"Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema","volume":"6","author":"Quaranta","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib6","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/all.13839","article-title":"Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity","volume":"74","author":"Thijs","year":"2019","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaci.2017.03.023","article-title":"Moving toward endotypes in atopic dermatitis: identification of patient clusters based on serum biomarker analysis","volume":"140","author":"Thijs","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaip.2019.08.013","article-title":"Atopic dermatitis endotypes based on allergen sensitization, reactivity to Staphylococcus aureus antigens, and underlying systemic inflammation","volume":"8","author":"Leonard","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaut.2021.102634_bib9","article-title":"Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers","author":"Bakker","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib10","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2013.09.015","article-title":"Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects","volume":"133","author":"Margolis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/jid.2011.342","article-title":"Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect","volume":"132","author":"Brown","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jaci.2012.07.008","article-title":"The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort","volume":"130","author":"Margolis","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2021.102634_bib14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13-dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder","volume":"137","author":"Brunner","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1523-1747.ep12329617","article-title":"Immunoglobulin E response to human proteins in atopic patients","volume":"107","author":"Valenta","year":"1996","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.jaut.2021.102634_bib17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2009.02132.x","article-title":"EAACI\/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria","volume":"64","author":"Konstantinou","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/000155502320624050","article-title":"IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis","volume":"82","author":"Hide","year":"2002","journal-title":"Acta Derm. Venereol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib19","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.4049\/jimmunol.147.11.3794","article-title":"Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis","volume":"147","author":"Taylor","year":"1991","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.175.2.1286","article-title":"Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity","volume":"175","author":"Aichberger","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2021.102634_bib21","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","article-title":"Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis","volume":"128","author":"Altrichter","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2021.102634_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13601-020-00338-7","article-title":"IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis","volume":"10","author":"Badloe","year":"2020","journal-title":"Clin. Transl. Allergy"},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/jid.2014.25","article-title":"Cytokine effects induced by the human autoallergen \u03b1-NAC","volume":"134","author":"Hradetzky","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1398-9995.2003.00330.x","article-title":"IgE-binding components of cultured human keratinocytes in atopic eczema\/dermatitis syndrome and their crossreactivity with Malassezia furfur","volume":"59","author":"Kortekangas-Savolainen","year":"2004","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.178.1.389","article-title":"Cross-reactivity and 1.4-A crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family","volume":"178","author":"Limacher","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.jid.5701195","article-title":"The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gamma","volume":"128","author":"Mittermann","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1046\/j.1523-1747.2002.00518.x","article-title":"Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgE-defined autoantigen","volume":"119","author":"Mossabeb","year":"2002","journal-title":"J. Invest. Dermatol."},{"issue":"14","key":"10.1016\/j.jaut.2021.102634_bib28","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1096\/fasebj.12.14.1559","article-title":"Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients","volume":"12","author":"Natter","year":"1998","journal-title":"Faseb. J."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2005.01.065","article-title":"IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis","volume":"115","author":"Schmid-Grendelmeier","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000024229","article-title":"Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity","volume":"120","author":"Seiberler","year":"1999","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08916934.2010.549157","article-title":"IgE and IgG(4) autoantibodies against DFS70\/LEDGF in atopic dermatitis","volume":"44","author":"Watanabe","year":"2011","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2011.02.043","article-title":"Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis","volume":"128","author":"Balaji","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/ACI.0000000000000308","article-title":"Atopic dermatitis: new evidence on the role of allergic inflammation","volume":"16","author":"Heratizadeh","year":"2016","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187221312802652820","article-title":"Atopic dermatitis and cytokines: recent patents in immunoregulatory and therapeutic implications of cytokines in atopic dermatitis--part I: cytokines in atopic dermatitis","volume":"6","author":"Lee","year":"2012","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"issue":"10","key":"10.1016\/j.jaut.2021.102634_bib37","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1084\/jem.20120905","article-title":"Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection","volume":"209","author":"Enouz","year":"2012","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2016.04.036","article-title":"Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor I\u03b1 subunit","volume":"138","author":"Auyeung","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102634_bib39","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3389\/fimmu.2019.02016","article-title":"Continuous developmental and early life trichloroethylene exposure promoted DNA methylation alterations in polycomb protein binding sites in effector\/memory CD4(+) T cells","volume":"10","author":"Byrum","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib40","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.jaci.2018.11.048","article-title":"Inhibitory checkpoint receptors control CD8(+) resident memory T cells to prevent skin allergy","volume":"143","author":"Gamradt","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2133.2010.10090.x","article-title":"The role of T-cell reactivity towards the autoantigen \u03b1-NAC in atopic dermatitis","volume":"164","author":"Heratizadeh","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12192-012-0361-3","article-title":"Recognition of self-heat shock protein 60 by T cells from patients with atopic dermatitis","volume":"18","author":"Kapitein","year":"2013","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1034\/j.1399-0039.2003.00046.x","article-title":"IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients","volume":"61","author":"Kawamoto","year":"2003","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2019.04.020","article-title":"Walnut antigens can trigger autoantibody development in patients with pemphigus vulgaris through a \"hit-and-run\" mechanism","volume":"144","author":"Lin","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2021.102634_bib45","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/eji.200839195","article-title":"IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema","volume":"39","author":"Lind","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2021.102634_bib46","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.1500351","article-title":"\u03b1-NAC-Specific autoreactive CD8+ T cells in atopic dermatitis are of an effector memory type and secrete IL-4 and IFN-\u03b3","volume":"196","author":"Roesner","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib47","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1038\/s41598-019-47769-2","article-title":"Human thioredoxin, a damage-associated molecular pattern and Malassezia-crossreactive autoallergen, modulates immune responses via the C-type lectin receptors Dectin-1 and Dectin-2","volume":"9","author":"Roesner","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib49","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jid.2019.05.006","article-title":"Keratinocytes share gene expression fingerprint with epidermal langerhans cells via mRNA transfer","volume":"139","author":"Su","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/all.13080","article-title":"Circulating CLA(+) T cells in atopic dermatitis and their possible role as peripheral biomarkers","volume":"72","author":"Czarnowicki","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib52","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/jid.2015.23","article-title":"NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity","volume":"135","author":"Nielsen","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \"autoreactivity\" play a role in atopic dermatitis?","volume":"129","author":"Tang","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib54","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.93.6.2257","article-title":"Viruses, cytokines, antigens, and autoimmunity","volume":"93","author":"Gianani","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib55","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","article-title":"Molecular mimicry and autoimmune disease","volume":"50","author":"Oldstone","year":"1987","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib56","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/sj.jid.5700431","article-title":"Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema","volume":"126","author":"Casagrande","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib57","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1111\/all.14461","article-title":"Skin pH-dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity","volume":"75","author":"H\u00fclp\u00fcsch","year":"2020","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jdv.17164","article-title":"The emerging role of autoreactive antibodies in inflammatory skin diseases","volume":"35","author":"Kortekaas Krohn","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib59","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jdv.16996","article-title":"IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients","volume":"35","author":"Lamberts","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2021.102634_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-beta","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2021.102634_bib62","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41590-018-0200-5","article-title":"An immunoregulatory and tissue-residency program modulated by c-MAF in human T(H)17 cells","volume":"19","author":"Aschenbrenner","year":"2018","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib64","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190472","article-title":"IL-21 is a broad negative regulator of IgE class switch recombination in mouse and human B cells","volume":"217","author":"Yang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102634_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000506285","article-title":"In vitro conversion into CD4+CD25+Foxp3+ induced regulatory T cells is reduced in atopic dermatitis patients","volume":"181","author":"Garc\u00eda","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2005.10.040","article-title":"Absence of T-regulatory cell expression and function in atopic dermatitis skin","volume":"117","author":"Verhagen","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2021.102634_bib68","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00403-012-1290-9","article-title":"T-regulatory cells in severe atopic dermatitis: alterations related to cytokines and other lymphocyte subpopulations","volume":"304","author":"Samochocki","year":"2012","journal-title":"Arch. Dermatol. Res."},{"issue":"13","key":"10.1016\/j.jaut.2021.102634_bib69","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1073\/pnas.1917834117","article-title":"Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6(+)B helper T cells in systemic lupus erythematosus","volume":"117","author":"Facciotti","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/intimm\/dxv079","article-title":"T follicular helper cells, T follicular regulatory cells and autoimmunity","volume":"28","author":"Zhu","year":"2016","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib71","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2013.02.024","article-title":"Follicular helper T cells may play an important role in the severity of primary Sj\u00f6gren's syndrome","volume":"147","author":"Szabo","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102634_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.25032","article-title":"Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus","volume":"62","author":"Simpson","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib75","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/all.13340","article-title":"Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications","volume":"73","author":"Kortekaas Krohn","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib76","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/1346-8138.14696","article-title":"Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4(+) T cells in patients with atopic dermatitis","volume":"46","author":"Kurita","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2021.102634_bib78","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fimmu.2015.00418","article-title":"Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators","volume":"6","author":"Le Mercier","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.alit.2016.10.010","article-title":"Serum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions","volume":"66","author":"Mizutani","year":"2017","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib80","first-page":"47","article-title":"IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice","volume":"119","author":"Jin","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib81","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.jaci.2018.11.047","article-title":"IL-21 promotes allergic airway inflammation by driving apoptosis of FoxP3(+) regulatory T cells","volume":"143","author":"Tortola","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102634_bib82","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/ncomms4753","article-title":"IL-21 induces IL-22 production in CD4+ T cells","volume":"5","author":"Yeste","year":"2014","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jaut.2021.102634_bib83","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.jaut.2021.102634_bib84","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.4049\/jimmunol.179.12.8098","article-title":"IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis","volume":"179","author":"Kreymborg","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","article-title":"Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells","volume":"10","author":"Cupedo","year":"2009","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nri2522","article-title":"Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?","volume":"9","author":"Vivier","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2021.102634_bib88","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib89","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2021.102634_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib91","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib92","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.177.6.3635","article-title":"Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats","volume":"177","author":"Chang","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2021.102634_bib93","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/MIB.0000000000000105","article-title":"Cross-talk between ROR\u03b3t+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease","volume":"20","author":"Mizuno","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib94","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.jaut.2021.102634_bib95","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.181.7.5147","article-title":"Gene expression profiling in autoimmune noninfectious uveitis disease","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib96","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib97","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03511.x","article-title":"A role for T cell-derived interleukin 22 in psoriatic skin inflammation","volume":"150","author":"Boniface","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2021.102634_bib98","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib99","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaci.2015.03.032","article-title":"Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis","volume":"136","author":"Czarnowicki","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2021.102634_bib101","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.4049\/jimmunol.175.12.8003","article-title":"IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation","volume":"175","author":"Janas","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102634_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12865-014-0036-1","article-title":"Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells","volume":"15","author":"Lin","year":"2014","journal-title":"BMC Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib103","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1684\/ejd.2013.2011","article-title":"Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo","volume":"23","author":"Zhang","year":"2013","journal-title":"Eur. J. Dermatol."},{"issue":"9","key":"10.1016\/j.jaut.2021.102634_bib104","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.178.9.5571","article-title":"Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions","volume":"178","author":"Hennino","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jaci.2010.11.022","article-title":"CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis","volume":"127","author":"Hennino","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib106","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1260215","article-title":"Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis","volume":"6","author":"Ortner","year":"2017","journal-title":"OncoImmunology"},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib107","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","article-title":"Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity","volume":"30","author":"Klose","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(99)70128-4","article-title":"Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity","volume":"104","author":"Shimada","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib109","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1523-1747.2002.00132.x","article-title":"Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction","volume":"119","author":"Buentke","year":"2002","journal-title":"J. Invest. Dermatol."},{"issue":"7264","key":"10.1016\/j.jaut.2021.102634_bib110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nature08402","article-title":"Membrane-bound Fas ligand only is essential for Fas-induced apoptosis","volume":"461","author":"LA","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102634_bib111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2125.2012.04362.x","article-title":"New trends in allergy and atopic eczema","volume":"75","author":"Corrigan","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5114\/ceji.2017.70975","article-title":"Air pollution, oxidative stress, and exacerbation of autoimmune diseases","volume":"42","author":"Gawda","year":"2017","journal-title":"Cent. Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2021.102634_bib113","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1164\/rccm.200701-036OC","article-title":"Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children","volume":"177","author":"Morgenstern","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib114","article-title":"Indoor air pollution aggravates symptoms of atopic dermatitis in children","volume":"10","author":"Kim","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaci.2013.04.019","article-title":"Symptoms of atopic dermatitis are influenced by outdoor air pollution","volume":"132","author":"Kim","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib116","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frosteg\u00e5rd","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102634_bib117","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.envres.2015.11.017","article-title":"Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region","volume":"145","author":"Angelici","year":"2016","journal-title":"Italy. Environ Res."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000067108","article-title":"Ambient air quality and occurrence of multiple sclerosis relapse","volume":"22","author":"Oikonen","year":"2003","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib119","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2298\/VSP140121030V","article-title":"Disease relapses in multiple sclerosis can be influenced by air pollution and climate seasonal conditions","volume":"72","author":"Vojinovi\u0107","year":"2015","journal-title":"Vojnosanit. Pregl."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaci.2014.07.060","article-title":"Application of moisturizer to neonates prevents development of atopic dermatitis","volume":"134","author":"Horimukai","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib121","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","article-title":"Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention","volume":"134","author":"Simpson","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl 3","key":"10.1016\/j.jaut.2021.102634_bib122","article-title":"Therapeutic modulation of cutaneous autoimmunity by regulatory T cells","volume":"45","author":"Loser","year":"2006","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib123","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2337\/db19-0061","article-title":"Immunomodulation followed by antigen-specific T(reg) infusion controls islet autoimmunity","volume":"69","author":"Cabello-Kindelan","year":"2020","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jaut.2021.102634_bib124","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/08916934.2014.915954","article-title":"KN-93, an inhibitor of calcium\/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3\u207a regulatory T cells in MRL\/lpr mice","volume":"47","author":"Koga","year":"2014","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.clim.2015.01.006","article-title":"A77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory T cells and inhibiting IL-17-producing double negative T cells","volume":"157","author":"Qiao","year":"2015","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib126","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000330330","article-title":"Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response","volume":"223","author":"Quaglino","year":"2011","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.jaut.2021.102634_bib128","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib129","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg cell differentiation and function by the interleukin-21-mechanistic target of rapamycin Axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaad.2018.10.070","article-title":"Topical use of mammalian target of rapamycin inhibitors in dermatology: a systematic review with meta-analysis","volume":"80","author":"Leducq","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamapediatrics.2019.4476","article-title":"Treatment effect of omalizumab on severe pediatric atopic dermatitis: the ADAPT randomized clinical trial","volume":"174","author":"Chan","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.jaut.2021.102634_bib133","first-page":"990","article-title":"Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study","volume":"8","author":"Heil","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000350486","article-title":"Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial","volume":"162","author":"Iyengar","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2021.102634_bib135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","article-title":"Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study","volume":"135","author":"Saini","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2021.102634_bib137","article-title":"Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis","author":"Siegels","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2021.102634_bib138","article-title":"Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study","volume":"56","author":"Papaioannou","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib139","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jaci.2007.08.060","article-title":"Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels","volume":"120","author":"Belloni","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"14","key":"10.1016\/j.jaut.2021.102634_bib140","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1900408","article-title":"Ligelizumab for chronic spontaneous urticaria","volume":"381","author":"Maurer","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib141","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/all.14080","article-title":"Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry","volume":"75","author":"Ari\u00ebns","year":"2020","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib142","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102634_bib143","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jaut.2021.102634_bib144","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","article-title":"Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib146","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","article-title":"Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study","volume":"82","author":"Deleuran","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib147","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib148","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2021.102634_bib149","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jdv.15301","article-title":"JAK1\/3 inhibition preserves epidermal morphology in full-thickness 3D skin models of atopic dermatitis and psoriasis","volume":"33","author":"Clarysse","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jaut.2021.102634_bib151","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/all.14050","article-title":"Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis","volume":"75","author":"Kang","year":"2020","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.jaut.2021.102634_bib152","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000095299","article-title":"No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients","volume":"141","author":"Oldhoff","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2021.102634_bib153","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jaut.2021.102634_bib154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/exd.13112","article-title":"Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"26","author":"Khattri","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.jaut.2021.102634_bib155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/09546634.2017.1406894","article-title":"A systematic review of ustekinumab in the treatment of atopic dermatitis","volume":"29","author":"Pan","year":"2018","journal-title":"J. Dermatol. Treat."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:27:57Z","timestamp":1760257677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":155,"alternative-id":["S0896841121000421"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102634","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoreactive T cells and their role in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102634"}}